100 related articles for article (PubMed ID: 8241107)
1. Organization of von Willebrand factor on surface-activated platelets.
Escolar G; White JG
Arterioscler Thromb; 1993 Dec; 13(12):1852-8. PubMed ID: 8241107
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
[TBL] [Abstract][Full Text] [Related]
3. Redistribution of GPIb/IX and GPIIb/IIIa during spreading of discoid platelets.
White JG; Krumwiede MD; Johnson DK; Escolar G
Br J Haematol; 1995 Jul; 90(3):633-44. PubMed ID: 7647005
[TBL] [Abstract][Full Text] [Related]
4. Influence of combined thrombin stimulation, surface activation, and receptor occupancy on organization of GPIb/IX receptors on human platelets.
White JG; Krumwiede M; Cocking-Johnson D; Escolar G
Br J Haematol; 1994 Sep; 88(1):137-48. PubMed ID: 7803236
[TBL] [Abstract][Full Text] [Related]
5. Uptake of vWF-anti-vWF complexes by platelets in suspension.
White JG; Krumwiede MD; Cocking-Johnson DJ; Escolar G
Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):868-77. PubMed ID: 8673562
[TBL] [Abstract][Full Text] [Related]
6. Induction of GPIb/IX-vWF receptor-ligand translocation on surface-activated platelets.
White JG; Krumwiede MD; Cocking-Johnson D; Escolar G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):642-54. PubMed ID: 7749877
[TBL] [Abstract][Full Text] [Related]
7. Dynamic redistribution of glycoprotein Ib/IX on surface-activated platelets. A second look.
White JG; Krumwiede MD; Cocking-Johnson DJ; Escolar G
Am J Pathol; 1995 Oct; 147(4):1057-67. PubMed ID: 7573351
[TBL] [Abstract][Full Text] [Related]
8. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
9. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.
Berndt MC; Du XP; Booth WJ
Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575
[TBL] [Abstract][Full Text] [Related]
10. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.
Arya M; Anvari B; Romo GM; Cruz MA; Dong JF; McIntire LV; Moake JL; López JA
Blood; 2002 Jun; 99(11):3971-7. PubMed ID: 12010796
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
Cooney KA; Lyons SE; Ginsburg D
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
13. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
15. Enhanced ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib in patients with steroid-responsive nephrotic syndrome.
Taira K; Kamitsuji H; Okajima C; Fujimura Y
Haemostasis; 1990; 20(4):219-28. PubMed ID: 2242824
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
17. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
18. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
19. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
Carew JA; Quinn SM; Stoddart JH; Lynch DC
J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
